Financial Daily from THE HINDU group of publications
Tuesday, Jan 24, 2006


Group Sites

Corporate - New Projects

Manipal AcuNova opens clinical research centre near Bangalore

Our Bureau

"This clinical research centre will bring under one roof our key offerings in drug development and research for the pharmaceutical industry."

Bangalore , Jan. 23

Bangalore-based contract research organisation Manipal AcuNova launched its Asia Clinical Research Centre at Whitefield near here on Monday.

Set up with an investment of around Rs 9 crore, the centre will support research related to clinical drug development and drug discovery with focus on the global market.

It would hire 150 professionals for various skills, said Mr D.A. Prasanna, Vice-Chairman & MD, Manipal AcuNova. Manipal AcuNova, set up 10 months ago as a venture of Manipal Education & Medical Group and AcuNova Life Sciences P Ltd, has completed two studies for GE Healthcare related to parkinsonism and diabetes-related cardiac problems.

Sir William Castell, Vice-Chairman of GE and Chairman of GE Healthcare, who inaugurated the facility, signed an MoU with Manipal for further collaborations in the coming years. GE expected to reach its diagnostic products to the market at least a couple of years sooner by outsourcing research to Asian centres such as Manipal's. "We expect a large number of trials to be conducted in India, covering at least 600-800 patients a year," he said.

Mr Prasanna said, "This clinical research centre will bring under one roof our key offerings in drug development and research for the pharmaceutical industry.

Locating the centre in Bangalore helps co-locating with leading healthcare research companies like GE Healthcare and the opportunity to integrate our clinical research practice with high quality IT Infrastructure."

The new facility houses a central reference lab, radiology core lab and a cardiac safety monitoring lab.

Manipal AcuNova COO, Dr Ramananda Nadig, said the CRO has n in-house expertise of 1,300 physicians of the Manipal Network of Hospitals and access to over 1.2 million patients per year. It has conducted 22 studies ranging from phase 2 to phase 4 in varied therapeutic areas. Its clients include Aventis, Biocon, GE Healthcare, Novartis and Quntiles. The CRO, which has raised Rs 11 crore from IL&FS, has said it aims to be the number 1 CRO in the country.

More Stories on : New Projects

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
PNM Commodities office at Anakapalle

Nagarjuna bags SBI order
Kinetic Motors pref allotment
Avon Organics mulls pref issue
Quality award for Manipal Hospital
Vedanta Resources launches $725-m convertible bonds
EIH board clears restructuring plan
Teva-Ivax merger likely to create shifts in pharma sector
HLL completes transfer of Doom Dooma to McLeod Russel
Reliance plans Rs 6,000-cr IPO for refinery project — To invest Rs 3,315 cr in retail biz
When `red tape' helped Chemplast shareholders
Manipal AcuNova opens clinical research centre near Bangalore
Toyota workers call off strike; want co not to insist on conduct note
Inox states changes in regulatory framework as risk factor for IPO
ONGC set to start deepwater projects in K-G basin by June
Media Video plans investments in video games, real estate
Shinco plans to launch portable DVD players

The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line